Detailed information for compound 832812

Basic information

Technical information
  • TDR Targets ID: 832812
  • Name: 2-fluoro-N-[[3-(4-methoxyphenyl)-1,2,4-oxadia zol-5-yl]methyl]-N-propan-2-ylbenzamide
  • MW: 369.39 | Formula: C20H20FN3O3
  • H donors: 0 H acceptors: 3 LogP: 3.66 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc(cc1)c1noc(n1)CN(C(=O)c1ccccc1F)C(C)C
  • InChi: 1S/C20H20FN3O3/c1-13(2)24(20(25)16-6-4-5-7-17(16)21)12-18-22-19(23-27-18)14-8-10-15(26-3)11-9-14/h4-11,13H,12H2,1-3H3
  • InChiKey: TXWVTFRVRVGLPR-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 2-fluoro-N-isopropyl-N-[[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]benzamide
  • 2-fluoro-N-[[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]-N-propan-2-yl-benzamide
  • STK321941
  • ZINC04838802

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus cathepsin b 0.1165 1 1
Giardia lamblia Cathepsin B precursor 0.0426 0.1854 0.5
Plasmodium falciparum cysteine proteinase falcipain 3 0.0258 0 0.5
Schistosoma mansoni cathepsin B-like peptidase (C01 family) 0.1165 1 1
Onchocerca volvulus 0.0258 0 0.5
Onchocerca volvulus 0.0258 0 0.5
Trypanosoma cruzi cysteine peptidase C (CPC), putative 0.1165 1 1
Onchocerca volvulus 0.0258 0 0.5
Loa Loa (eye worm) cathepsin B 0.0426 0.1854 0.1854
Onchocerca volvulus 0.0258 0 0.5
Plasmodium vivax vivapain-2 0.0258 0 0.5
Onchocerca volvulus 0.0258 0 0.5
Giardia lamblia Cathepsin B precursor 0.0426 0.1854 0.5
Entamoeba histolytica cysteine proteinase, putative 0.0258 0 0.5
Entamoeba histolytica cysteine proteinase, putative 0.0258 0 0.5
Onchocerca volvulus Cathepsin L homolog 0.0258 0 0.5
Onchocerca volvulus 0.0258 0 0.5
Schistosoma mansoni cathepsin B-like peptidase (C01 family) 0.1165 1 1
Giardia lamblia Cathepsin B precursor 0.0426 0.1854 0.5
Echinococcus multilocularis cathepsin b 0.1165 1 1
Schistosoma mansoni SmCB2 peptidase (C01 family) 0.1165 1 1
Schistosoma mansoni cathepsin B-like peptidase (C01 family) 0.1165 1 1
Loa Loa (eye worm) hypothetical protein 0.1165 1 1
Toxoplasma gondii cathepsin B 0.0426 0.1854 1
Onchocerca volvulus Cathepsin L homolog 0.0258 0 0.5
Trypanosoma brucei cysteine peptidase C (CPC) 0.0426 0.1854 1
Plasmodium falciparum cysteine proteinase falcipain 2b 0.0258 0 0.5
Trichomonas vaginalis Clan CA, family C1, cathepsin B-like cysteine peptidase 0.0426 0.1854 1
Leishmania major cysteine peptidase C (CPC),CPC cysteine peptidase, Clan CA, family C1, Cathepsin B-like 0.0426 0.1854 1
Trypanosoma cruzi cysteine peptidase C (CPC), putative 0.0426 0.1854 0.1854
Onchocerca volvulus 0.0258 0 0.5
Echinococcus granulosus cathepsin b 0.1165 1 1
Entamoeba histolytica cysteine protease, putative 0.0258 0 0.5
Schistosoma mansoni cathepsin B-like peptidase (C01 family) 0.0426 0.1854 0.1854
Plasmodium falciparum cysteine proteinase falcipain 2a 0.0258 0 0.5
Entamoeba histolytica cysteine proteinase, putative 0.0258 0 0.5
Plasmodium vivax vivapain-2 0.0258 0 0.5
Onchocerca volvulus Cathepsin F homolog 0.0258 0 0.5
Echinococcus multilocularis cathepsin b 0.1165 1 1
Onchocerca volvulus 0.0258 0 0.5

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.